We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The EMA’s Committee for Medicinal Products for Human Use (CHMP) gave its blessing for European Commission approval of two drugs at its February meeting, including a generic version of Pfizer’s skin infection medication Tygacil (tigecycline). Read More
Drugs approved through the FDA’s Unapproved Drug Initiative could potentially cost $29 billion in extra healthcare costs, Vizient said in a new analysis released this week. Read More
The committee advised that drugs containing cyproterone only be used for reduced sex drive in men when other treatments are deemed unsuitable. Read More
The World Health Organization (WHO) has launched a pilot program aimed at increasing insulin access by prequalifying biotherapeutic products that contain human insulin as an active ingredient. Read More